St. Jude Medical, Inc., a global medical device company, has received CE Mark approval of its ILUMIEN OPTIS PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients ...
ST. PAUL, Minn., May 16, 2013 (BUSINESS WIRE) -- St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced CE Mark approval of its ILUMIEN(TM) OPTIS(TM) PCI Optimization System(TM), a new technology designed to ...
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the Population Health Research Institute (PHRI), an academic health science research institute, has conducted a further independent analysis of data received from ...
Below is a chart of Roper Industries, Inc versus St. Jude Medical, Inc. plotting their respective size rank within the S&P 500 over time (ROP plotted in blue; STJ plotted in green): Loading+chart+�+2013+TickerTech.
St. Jude Medical, Inc. (NYSE: STJ) develops, manufactures and distributes cardiovascular medical devices. Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter ...
St. Jude Medical Inc. (STJ)'s Durata lead, the wire used to connect life-saving defibrillators to the heart, proved safe and reliable in an independent review that should ease concerns about its use, researchers said.
St. Jude Medical logo Barclays Capital reaffirmed their overweight rating on shares of St. Jude Medical (NYSE: STJ) in a research note released on Thursday morning, AnalystRatingsNetwork.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.